Fidson Healthcare

Fidson Healthcare EBIT per Share

The EBIT per Share of Fidson Healthcare (FIDSON.NL) as of Oct 31, 2026 is 7.70 NGN. In the previous year, EBIT per Share was 3.83 NGN — a change of 100.91% (higher).

EBIT per Share

7.70NGN

YoY

100.91%

Last updated:

EBIT per Share of Fidson Healthcare is 2024 7.70 NGN. EBIT per Share of Fidson Healthcare was 2023 3.83 NGN. It decreases by 100.91% higher compared to the previous year.

The Fidson Healthcare EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2017
1.51 NGN
Jan 1, 2018
1.21 NGN
Jan 1, 2019
0.93 NGN
Jan 1, 2020
1.28 NGN
Jan 1, 2021
3.34 NGN
Jan 1, 2022
3.74 NGN
Jan 1, 2023
3.83 NGN
Jan 1, 2024
7.70 NGN
The Fidson Healthcare EBIT per Share history
YEAREBIT per ShareYoY
7.70NGN+100.91%
3.83NGN+2.37%
3.74NGN+12.13%
3.34NGN+160.79%
1.28NGN+37.68%
0.93NGN-23.18%
1.21NGN-20.01%
1.51NGN+135.92%
0.64NGN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fidson Healthcare Stock analysis

What does Fidson Healthcare do? Fidson Healthcare Plc manufactures and distributes pharmaceutical products, including drugs, infusion and injectables, across its segments: over-the-counter, ethical products, and consumer. The over-the-counter segment sells products directly to consumers without prescriptions, while the ethical products segment offers prescription-only drugs, injectables, and infusions. The consumer segment focuses on household items. The company provides formulation/development, contract manufacturing, and production services for medicines. Its product portfolio includes Anti Infective & Anti Malaria, Central Nervous System (CNS), Gastrointestinal Medicines, Supplements, Topical/Dermatological Medicines, Vitamins & Minerals, Ophthalmic Solution, and others, with Ophthalmic Solution specifically targeting eye conditions. The company's primary revenue streams come from the sale of pharmaceutical products within its three segments. Over-the-counter products are purchased by general consumers, ethical products are bought by healthcare providers and pharmacies requiring prescriptions, and consumer segment items are sold to households. Fidson Healthcare Plc serves the Nigerian market through its manufacturing and distribution network, leveraging its full-time workforce of 593 employees to support operations. Fidson Healthcare Plc's product lines are tailored to specific market needs, with Anti Infective & Anti Malaria products addressing infectious diseases, CNS medications targeting neurological disorders, and Ophthalmic Solution treating eye conditions. The company's services in formulation/development and contract manufacturing further generate revenue by supporting other pharmaceutical firms in product creation and production. Fidson Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fidson Healthcare stock

EBIT per Share of Fidson Healthcare is 7.70 NGN in 2024.

EBIT per Share of Fidson Healthcare changed from 3.83 NGN to 7.70 NGN, representing a 100.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Fidson Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Fidson Healthcare

All Key Metrics — Fidson Healthcare